Ikena Oncology, Inc.IKNANASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-2.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -103.35% |
| Q3 2025 | 149.91% |
| Q2 2025 | -21.76% |
| Q1 2025 | -25.69% |
| Q4 2024 | 58.99% |
| Q3 2024 | -10.00% |
| Q2 2024 | -11.52% |
| Q1 2024 | -27.66% |
| Q4 2023 | 37.44% |
| Q3 2023 | 13.38% |
| Q2 2023 | 0.87% |
| Q1 2023 | 7.13% |
| Q4 2022 | -9.27% |
| Q3 2022 | -7.13% |
| Q2 2022 | -2.63% |
| Q1 2022 | 18.01% |
| Q4 2021 | 3.96% |
| Q3 2021 | 0.64% |
| Q2 2021 | 53.23% |
| Q1 2021 | 16.83% |
| Q4 2020 | 47.29% |
| Q3 2020 | 2.56% |
| Q2 2020 | -28.37% |
| Q1 2020 | 9.94% |
| Q4 2019 | 0.00% |